Shanghai ZJ Bio-Tech Co

Shanghai ZJ Bio-Tech Co Book Value per Share

The Book Value per Share of Shanghai ZJ Bio-Tech Co (688317.SS) as of Nov 4, 2026 is 17.43 CNY. In the previous year, Book Value per Share was 18.93 CNY — a change of -7.92% (lower).

Book Value per Share

17.43CNY

YoY

-7.92%

Last updated:

Book Value per Share of Shanghai ZJ Bio-Tech Co is 2025 17.43 CNY. Book Value per Share of Shanghai ZJ Bio-Tech Co was 2024 18.93 CNY. It decreases by -7.92% lower compared to the previous year.

The Shanghai ZJ Bio-Tech Co Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
2.77 CNY
Jan 1, 2019
2.98 CNY
Jan 1, 2020
7.61 CNY
Jan 1, 2021
19.92 CNY
Jan 1, 2022
21.86 CNY
Jan 1, 2023
19.90 CNY
Jan 1, 2024
18.93 CNY
Jan 1, 2025
17.43 CNY
The Shanghai ZJ Bio-Tech Co Book Value per Share history
YEARBook Value per ShareYoY
17.43CNY-7.92%
18.93CNY-4.92%
19.90CNY-8.94%
21.86CNY+9.75%
19.92CNY+161.69%
7.61CNY+155.77%
2.98CNY+7.36%
2.77CNY+12.69%
2.46CNY-2.29%
2.52CNY+40.91%
1.79CNY+211.58%
0.57CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai ZJ Bio-Tech Co Stock analysis

What does Shanghai ZJ Bio-Tech Co do? Shanghai ZJ Bio-Tech Co., Ltd. generates revenue through the research, development, production, and sale of molecular diagnostic reagents and instruments. The company's primary products are nucleic acid detection kits and molecular diagnostic instruments, which are sold to customers in sectors including emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. The firm focuses its business activities within the domestic market, targeting institutions and organizations requiring diagnostic solutions for public health and clinical applications. The company's business model centers on providing diagnostic reagents and equipment for critical applications such as emergency public health safety and medical clinical diagnosis. Its products are designed to meet the needs of domestic customers in healthcare, public safety, and food safety sectors, with a strong emphasis on molecular diagnostics. Shanghai ZJ Bio-Tech leverages its domestic market presence to serve institutions requiring reliable diagnostic tools for health and safety monitoring. Shanghai ZJ Bio-Tech Co., Ltd. operates with a domestic market focus, selling its molecular diagnostic instruments and reagents to entities involved in public health, clinical diagnosis, and food safety. The firm's revenue streams are derived from the sale of nucleic acid detection kits and molecular diagnostic instruments, which are essential for applications in emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. Shanghai ZJ Bio-Tech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai ZJ Bio-Tech Co stock

Book Value per Share of Shanghai ZJ Bio-Tech Co is 17.43 CNY in 2025.

Book Value per Share of Shanghai ZJ Bio-Tech Co changed from 18.93 CNY to 17.43 CNY, representing a -7.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Shanghai ZJ Bio-Tech Co since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Shanghai ZJ Bio-Tech Co

All Key Metrics — Shanghai ZJ Bio-Tech Co